Exercise modulation of BDNF/TrkB signaling in Parkinson’s disease: an evidence-calibrated review of neuroprotective mechanisms, biomarker limitations, and translational gaps - Top-Institutions - MDSpire

Exercise modulation of BDNF/TrkB signaling in Parkinson’s disease: an evidence-calibrated review of neuroprotective mechanisms, biomarker limitations, and translational gaps

  • By

  • Chuan Chen

  • Kaihua Liu

  • Meng Xiang

  • Xueqin Zhang

  • June 25, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Northwestern Medicine – Northwestern Memorial Hospital; Feinberg School of Medicine Parkinson’s Disease & Movement Disorders Center
    Northwestern Medicine – Northwestern Memorial Hospital; Feinberg School of Medicine Parkinson’s Disease & Movement Disorders Center

    Chicago, Illinois

    Key Differentiators

    • Neurology
    • Movement Disorders

  • #2

    Rush University Medical Center – Section of Parkinson’s Disease and Movement Disorders
    Rush University Medical Center – Section of Parkinson’s Disease and Movement Disorders

    Chicago, Illinois

    Key Differentiators

    • Neurology
    • Movement Disorders

Original Source(s)

Exercise modulation of BDNF/TrkB signaling in Parkinson’s disease: an evidence-calibrated review of neuroprotective mechanisms, biomarker limitations, and translational gaps

  • by Chuan Chen, Kaihua Liu, Meng Xiang, Xueqin Zhang

  • June 25, 2026

Related Content

How we diagnose and treat hereditary transthyretin-mediated amyloidosis with polyneuropathy in the Balkan region: an expert opinion

Combination of Yaobitong capsules and lumbar oblique pull manipulation for moderate pain in lumbar disc herniation with radiculopathy: a multicenter, randomized, three-arm, parallel-group controlled trial

Beta-2 Agonists Tied to ASD Risk?

Systematic review of 8 observational studies found limited evidence on associations between prenatal asthma-medication exposure and neurodevelopmental outcomes, with autism spectrum disorder the only outcome suitable for meta-analysis.